A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma
Clinical trial NCT01359696 · COMPLETED
Trial details
- NCT number
- NCT01359696
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-11
- Primary completion
- 2014-05-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.